International Breast Cancer Study Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Bern Switzerland (1977)

Organization Overview

First Clinical Trial
1993
NCT00002528
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

International Breast Cancer Study Group